News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Photo from Rami Manochakian/X
Apr 26, 2024, 10:07

Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer

Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter:

”HOT OFF THE PRESS.

BIG NEWS.

U.S. FDA approves adjuvant Alectinib following surgery in patients with stage IB-IIIA ALK+ Non-Small Cell Lung Cancer based on results of Alina trial:

High DFS HR: 0.24 (compared with adjuvant chemotherapy).”

Read further.
Source: Rami Manochakian/X

 

adjucant alectinib alectinib ALINA trial ALK Positive Lung CancerK cancer Cancer research chemotherapy clinical trial FDA approval Lung cancer Mayo Clinic non small cell lung cancer NSCLC OncoDaily Oncology Rami Manochakian U.S. FDA
Special Coverage
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer
Blog
Feb 21, 2025, 06:10
Afreen Shariff: Start-ups are about persistence, grit and being comfortable with being uncomfortable
Radiotherapy
Feb 21, 2025, 04:51
Radiotherapy For Breast Cancer: Types, Success Rate, Side Effects And More
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy
Blog
Feb 20, 2025, 11:13
Abstract submissions are open for the ESMO Gynae25
Blog
Feb 20, 2025, 11:08
Aleix Prat: In ten years we will cure 80% of cancers
Blog
Feb 20, 2025, 11:00
Akshaya Keerti: PCOS and the Hidden Risk of Endometrial Cancer
Blog
Feb 20, 2025, 10:53
Fumiko Ladd Chino: Optimizing the EHR for patient-centered communication and care